- Home
- CSPI vs UNCY Comparison
CSPI vs UNCY Comparison
Compare CSPI & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSPI
- UNCY
- Stock Information
- Founded
- CSPI 1968
- UNCY 2016
- Country
- CSPI United States
- UNCY United States
- Employees
- CSPI N/A
- UNCY N/A
- Industry
- CSPI EDP Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- CSPI Technology
- UNCY Health Care
- Exchange
- CSPI Nasdaq
- UNCY Nasdaq
- Market Cap
- CSPI 105.9M
- UNCY 91.0M
- IPO Year
- CSPI 1987
- UNCY 2021
- Fundamental
- Price
- CSPI $11.96
- UNCY $4.95
- Analyst Decision
- CSPI
- UNCY Strong Buy
- Analyst Count
- CSPI 0
- UNCY 4
- Target Price
- CSPI N/A
- UNCY $63.75
- AVG Volume (30 Days)
- CSPI 76.2K
- UNCY 1.2M
- Earning Date
- CSPI 08-12-2025
- UNCY 08-13-2025
- Dividend Yield
- CSPI 1.00%
- UNCY N/A
- EPS Growth
- CSPI N/A
- UNCY N/A
- EPS
- CSPI N/A
- UNCY N/A
- Revenue
- CSPI $54,955,000.00
- UNCY N/A
- Revenue This Year
- CSPI N/A
- UNCY N/A
- Revenue Next Year
- CSPI N/A
- UNCY $1,458.53
- P/E Ratio
- CSPI N/A
- UNCY N/A
- Revenue Growth
- CSPI N/A
- UNCY N/A
- 52 Week Low
- CSPI $10.39
- UNCY $2.02
- 52 Week High
- CSPI $21.95
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- CSPI 46.04
- UNCY 43.02
- Support Level
- CSPI $11.84
- UNCY $4.31
- Resistance Level
- CSPI $12.98
- UNCY $5.55
- Average True Range (ATR)
- CSPI 0.70
- UNCY 0.76
- MACD
- CSPI 0.23
- UNCY -0.10
- Stochastic Oscillator
- CSPI 58.60
- UNCY 16.26
About CSPI CSP Inc.
CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.